GALT - Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference | Benzinga
NORCROSS, Ga., May 13, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will be attending and presenting at the H.C. Wainwright 2nd Annual BioConnect Investor Conference. Detailed information about the presentation is below.
H.C. Wainwright 2nd Annual BioConnect Investor Conference
Format: Fireside chat
Date and time: May 20, 2024 at 4:00 PM ET
Location: Nasdaq World Headquarters, New York City
Webcast: https://journey.ct.events/view/e36631f4-3c58-4887-8d5b-1e7f6ce3bfe8
Galectin management team will be available for one-on-one meetings during the conferences. Interested investors should contact their representative at H.C. Wainwright. A Link to access ...